JACQUELINE JACKSON: Open Payments
NPI 1083118350 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,245 in 66 payments from 20 companies in 2025. Trend: 2023 $940 · 2024 $1,867 · 2025 $1,245
Food & beverage: $1,245
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $151 |
| PFIZER INC. | 8 | $150 |
| Lilly USA, LLC | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| ABBVIE INC. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 5 | $73 |
| Janssen Pharmaceuticals, Inc | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Radius Health, Inc. | 3 | $61 |
Products named: Wegovy, NURTEC ODT, VOQUEZNA, TRINTELLIX, SPRAVATO, MOUNJARO, XIFAXAN, VRAYLAR.
Industry payments across FL — which companies pay providers there.
